RENODAPT S 180MG TABLET

Renodapt S 180mg tablet is an immunosuppressant with Mycophenolate sodium as an active ingredient. It is part of the inosine monophosphate dehydrogenase (IMPDH) inhibitor class. The medicine is prescribed to avoid rejection of organs in patients who have received the organs of a donor (such as heart, kidney, and liver transplantation). It is usually prescribed as a part of a combination treatment that includes other immunosuppressive medicines.
This medication is not recommended during pregnancy because of the possibility of miscarriage and congenital disabilities. It is not recommended for pregnant women unless there are no other suitable alternatives and the benefits outweigh any risks. Women with reproductive potential are strongly advised to utilize effective contraception when using this tablet to avoid the possibility of pregnancy. Live vaccines shouldn’t be administered when a patient is using Renodapt S 180mg tablet due to the lower effectiveness of vaccines and the risk of getting ill. Patients taking this medication are not allowed to donate blood during treatment and, at minimum, six weeks after having stopped treatment. This ensures that the drug is eliminated from the body before blood donation is made.
It is usually advised not to take this drug when allergic to the medication or other ingredients. Inform your physician if you suffer from heart or liver disease before beginning treatment. Since this medication weakens the body’s immune defenses, it could increase the risk of developing skin cancer. People should reduce their exposure to sun and ultraviolet (UV) radiation. Contact your physician immediately when you experience skin bruising in your body, fever, unresolved fatigue, dizziness, or eyes, or skin eyes or eyes, vision impairment, a decrease in urine output, or seizures following this medication. Renodapt S 180mg tablet is an immunosuppressive drug. It could affect a baby’s growing immune system and must be avoided while breastfeeding.